"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
| Descriptor ID |
D015996
|
| MeSH Number(s) |
E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
| Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 21 | 21 |
| 1997 | 0 | 32 | 32 |
| 1998 | 0 | 42 | 42 |
| 1999 | 0 | 27 | 27 |
| 2000 | 0 | 33 | 33 |
| 2001 | 0 | 30 | 30 |
| 2002 | 0 | 31 | 31 |
| 2003 | 1 | 31 | 32 |
| 2004 | 0 | 33 | 33 |
| 2005 | 0 | 31 | 31 |
| 2006 | 0 | 32 | 32 |
| 2007 | 0 | 23 | 23 |
| 2008 | 0 | 51 | 51 |
| 2009 | 0 | 38 | 38 |
| 2010 | 0 | 69 | 69 |
| 2011 | 0 | 73 | 73 |
| 2012 | 0 | 59 | 59 |
| 2013 | 1 | 58 | 59 |
| 2014 | 0 | 59 | 59 |
| 2015 | 0 | 58 | 58 |
| 2016 | 1 | 63 | 64 |
| 2017 | 0 | 67 | 67 |
| 2018 | 1 | 52 | 53 |
| 2019 | 1 | 88 | 89 |
| 2020 | 0 | 67 | 67 |
| 2021 | 0 | 42 | 42 |
| 2022 | 0 | 11 | 11 |
| 2023 | 0 | 9 | 9 |
| 2024 | 0 | 52 | 52 |
| 2025 | 0 | 39 | 39 |
| 2026 | 0 | 12 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
Characterizing intradural spinal metastasis in the metastatic cascade: clinical course, dissemination timing, and molecular features in 69 patients. J Neurooncol. 2026 Sep 18; 179(3).
-
Robotic versus open post-chemotherapy retroperitoneal lymph node dissection: a propensity score matched study across 11 academic medical centers. World J Urol. 2026 Aug 28; 44(1).
-
Central Nervous System Neuroblastoma, FOXR2-Activated: A Pooled Analysis of Published Clinical Outcomes. Pediatr Blood Cancer. 2026 Sep; 73(9):e70445.
-
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Leukemia. 2026 Oct; 40(10):2181-2190.
-
Survival Outcomes in Early Onset Appendiceal Adenocarcinoma (EOAA). Ann Surg Oncol. 2026 Sep; 33(9):8546-8554.
-
CT-Based Assessment of Brain Edema May Predict Which Patients with Traumatic Brain Injury May Benefit from Tranexamic Acid. AJNR Am J Neuroradiol. 2026 Jun 03; 47(6):1695-1702.
-
Donor-Recipient Size Mismatch by Body Surface Area and Risk of Graft Failure in Kidney Transplantation. Clin Transplant. 2026 Jun; 40(6):e70596.
-
Multi-level disparities in survival among patients diagnosed with oral cavity cancer in Texas between 1995 and 2020. Cancer Epidemiol. 2026 Aug; 103:103086.
-
ENTRÉE Lung Platform Trial Sub-study 1: Phase II Randomized Efficacy and Safety Analysis of Feladilimab Plus Docetaxel Versus Docetaxel Monotherapy in Advanced/Recurrent NSCLC. Clin Lung Cancer. 2026 Jun; 27(5):65-76.e2.
-
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Impact of Common Molecular Alterations and Programmed Death-Ligand 1 Expression on Overall Survival in a Select Cohort From the International Association for the Study of Lung Cancer Ninth Edition Staging Database. J Thorac Oncol. 2026 Jul; 21(7):103681.